Tokyo Tape
Sign in
← Kawaguchi Chemical Industry

Quarterly report · Q1

4361.TEDINET S100T7MO
Period2023-12-01 → 2024-02-29
Filed2024-04-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥2.0bn2023-12-01 → 2024-02-29Cons.Net sales
Revenue¥8.6bn2022-12-01 → 2023-11-30Cons.Net sales (5-year summary)
Revenue¥2.1bn2022-12-01 → 2023-02-28Cons.Net sales
Operating income¥68m2023-12-01 → 2024-02-29Cons.Operating income
Operating income¥47m2022-12-01 → 2023-02-28Cons.Operating income
Ordinary income¥67m2023-12-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥345m2022-12-01 → 2023-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥46m2022-12-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥67m2023-12-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥46m2022-12-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥50m2023-12-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥256m2022-12-01 → 2023-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥41m2022-12-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥50m2023-12-01 → 2024-02-29Cons.Profit loss
Net income¥41m2022-12-01 → 2023-02-28Cons.Profit loss
Total assets¥8.1bnat 2024-02-29Cons.Assets
Total assets¥8.3bnat 2023-11-30Cons.Assets
Total assets¥8.2bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥5.4bnat 2024-02-29Cons.Liabilities
Total liabilities¥5.7bnat 2023-11-30Cons.Liabilities
Net assets / equity¥2.6bnat 2024-02-29Cons.Net assets
Net assets / equity¥2.6bnat 2023-11-30Cons.Net assets
Net assets / equity¥2.4bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥906mat 2024-02-29Cons.Cash and deposits
Cash and deposits¥1.0bnat 2023-11-30Cons.Cash and deposits
EPS (basic)¥40.792023-12-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥209.882022-12-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥33.772022-12-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
Equity ratio32.5%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio31.6%at 2023-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio29.1%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segmentrevenue2023-12-01 → 2024-02-29¥2.0bn
jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2023-12-01 → 2024-02-29¥2.0bn
jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2023-12-01 → 2024-02-29¥60m
jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segmentrevenue2023-12-01 → 2024-02-29¥10m
jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segmentrevenue external2023-12-01 → 2024-02-29¥10m
jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segmentsegment profit2023-12-01 → 2024-02-29¥8m
Total Of Reportable Segments And Otherssegment totalrevenue2023-12-01 → 2024-02-29¥2.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-12-01 → 2024-02-29¥2.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-12-01 → 2024-02-29¥68m
jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segmentrevenue2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2022-12-01 → 2023-02-28¥39m
jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segmentrevenue2022-12-01 → 2023-02-28¥10m
jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segmentrevenue external2022-12-01 → 2023-02-28¥10m
jpcrp040300-q1r_E01006-000Real Estate Leasingreportable segmentsegment profit2022-12-01 → 2023-02-28¥8m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-02-28¥2.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-02-28¥2.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-02-28¥47m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 333
ItemContextValueUnit
Accrued consumption taxesPrior1YearInstant107916000JPY
Accrued consumption taxesCurrentQuarterInstant22231000JPY
Provision for bonusesPrior1YearInstant－JPY
Provision for bonusesCurrentQuarterInstant54336000JPY
Provision for directors bonusesPrior1YearInstant16200000JPY
Provision for directors bonusesCurrentQuarterInstant1350000JPY
Other clPrior1YearInstant308612000JPY
Other clCurrentQuarterInstant63097000JPY
Current liabilitiesPrior1YearInstant4761923000JPY
Current liabilitiesCurrentQuarterInstant4520649000JPY
Long term loans payablePrior1YearInstant534762000JPY
Long term loans payableCurrentQuarterInstant516148000JPY
Provision for directors retirement benefitsPrior1YearInstant79950000JPY
Provision for directors retirement benefitsCurrentQuarterInstant79278000JPY
Net defined benefit liabilityPrior1YearInstant194988000JPY
Net defined benefit liabilityCurrentQuarterInstant206353000JPY
Other nclPrior1YearInstant130545000JPY
Other nclCurrentQuarterInstant126233000JPY
Noncurrent liabilitiesPrior1YearInstant940246000JPY
Noncurrent liabilitiesCurrentQuarterInstant928013000JPY
LiabilitiesPrior1YearInstant5702170000JPY
LiabilitiesCurrentQuarterInstant5448662000JPY
Capital stockPrior1YearInstant610000000JPY
Capital stockCurrentQuarterInstant610000000JPY
Capital surplusPrior1YearInstant58437000JPY
Capital surplusCurrentQuarterInstant58437000JPY
Retained earningsPrior1YearInstant1881096000JPY
Retained earningsCurrentQuarterInstant1869882000JPY
Treasury stockPrior1YearInstant-8202000JPY
Treasury stockCurrentQuarterInstant-8202000JPY
Shareholders equityPrior1YearInstant2541332000JPY
Shareholders equityCurrentQuarterInstant2530118000JPY
Valuation difference on available for sale securitiesPrior1YearInstant46890000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant43332000JPY
Foreign currency translation adjustmentPrior1YearInstant50201000JPY
Foreign currency translation adjustmentCurrentQuarterInstant52825000JPY
Valuation and translation adjustmentsPrior1YearInstant97091000JPY
Valuation and translation adjustmentsCurrentQuarterInstant96158000JPY
Net assetsPrior1YearInstant2638424000JPY
Net assetsCurrentQuarterInstant2626277000JPY
Liabilities and net assetsPrior1YearInstant8340594000JPY
Liabilities and net assetsCurrentQuarterInstant8074939000JPY
Net salesPrior1YTDDuration2051990000JPY
Net salesCurrentYTDDuration1999928000JPY
Cost of salesPrior1YTDDuration1719648000JPY
Cost of salesCurrentYTDDuration1641878000JPY
Gross profitPrior1YTDDuration332342000JPY
Gross profitCurrentYTDDuration358050000JPY
Selling general and administrative expensesPrior1YTDDuration285837000JPY
Selling general and administrative expensesCurrentYTDDuration290547000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-11-30pass
balance sheet identityconsolidated 2024-02-29pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-12-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-12-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-12-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-11-30pass
statement vs summary · total assetsconsolidated 2024-02-29pass